Symbol="HALO"
AssetType="Common Stock"
Name="Halozyme Therapeutics Inc"
Description="Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company is headquartered in San Diego, California."
CIK="1159036"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="11388 SORRENTO VALLEY ROAD, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4820805000"
EBITDA="332883000"
PERatio="26.34"
PEGRatio="-2.5"
BookValue="0.5"
DividendPerShare="0"
DividendYield="0"
EPS="1.39"
RevenuePerShareTTM="5.18"
ProfitMargin="0.258"
OperatingMarginTTM="0.38"
ReturnOnAssetsTTM="0.117"
ReturnOnEquityTTM="1.114"
RevenueTTM="704980000"
GrossProfitTTM="454205000"
DilutedEPSTTM="1.39"
QuarterlyEarningsGrowthYOY="-0.326"
QuarterlyRevenueGrowthYOY="0.383"
AnalystTargetPrice="48.56"
TrailingPE="26.34"
ForwardPE="23.47"
PriceToSalesRatioTTM="13.28"
PriceToBookRatio="81.58"
EVToRevenue="15.76"
EVToEBITDA="31.48"
Beta="1.22"
num_52WeekHigh="59.46"
num_52WeekLow="29.85"
num_50DayMovingAverage="33.65"
num_200DayMovingAverage="43.77"
SharesOutstanding="131680000"
DividendDate="None"
ExDividendDate="None"
symbol="HALO"
open="36.59"
high="37.26"
low="36.32"
price="36.62"
volume="1164515.00"
latest_trading_day="2023-07-07"
previous_close="36.61"
change="0.01"
change_percent="0.0273%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="1427295"
Change_recent_avg="-0.11"
Delta_recent_avg="1.3"
Variance_recent_avg="0.65"
Change_ratio_recent_avg="-0.31"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1089"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0122.jpeg"
image_negative_thumbnail_id_2="503"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0102.jpeg"
image_neutral_thumbnail_id_1="546"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_neutral_thumbnail_id_2="590"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_positive_thumbnail_id_1="957"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0119.jpeg"
image_positive_thumbnail_id_2="1011"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0173.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
